Ignite Creation Date:
2024-05-06 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03603132
Status:
COMPLETED
Last Update Posted:
2019-05-07
First Post:
2018-06-18
Brief Title:
A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Study Overview
Official Title:
Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study use a single-center randomized open three-cycle self-control trial design It is planning to enroll 15 healthy adult male subjects Fifteen subjects will randomize into 3 test groups which corresponding to 3 different dosing sequences Subjects will be giving a single oral dose in per cycle and there will have three types of breakfast administration after each treatment Washing period is 10 days during the cycle
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None